Evaluation of the positive predictive value of rapid assays used by clinical laboratories in Minnesota for the diagnosis of cryptosporidiosis

Clinical Infectious Diseases

Volumn 50, Issue 8, 2010, Pages

  Robinson, Trisha J ^a   Cebelinski, Elizabeth A ^a   Taylor, Charlott ^a   Smith, Kirk E ^a  

^a MINNESOTA DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITAZOXANIDE;

ARTICLE; AWARENESS; CLINICAL EVALUATION; CLINICAL LABORATORY; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; PATHOLOGIST; PHYSICIAN; POLYMERASE CHAIN REACTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; UNITED STATES;

CLINICAL LABORATORY TECHNIQUES; CRYPTOSPORIDIOSIS; HUMANS; MINNESOTA; PREDICTIVE VALUE OF TESTS;

EID: 77950252207     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/651423     Document Type: Article

References (10)

1. Roy SL, Delong SM, Stenzel SA, et al. Risk factors for sporadic cryptosporidiosis among immunocompetent persons in the United States from 1999 to 2001. J Clin Microbiol 2004; 42(7):2944-2951.
2. Yoder JS, Beach MJ. Cryptosporidium surveillance and risk factors in the United States. Exp Parasitol 2010; 124(1):31-39 (published online ahead of print).
3. Minnesota Department of Health. Annual summary of communicable diseases reported to the Minnesota Department of Health, 2007. 2008. http://www.health. state.mn.us/divs/idepc/newsletters/dcn/2008/oct08.pdf. Accessed 17 February 2010.
4. Miller JR, Mojica B, Nadle J, et al. False-positive laboratory tests for Cryptosporidium involving an enzyme-linked immunosorbent assayUnited States, November 1997-March 1998. MMWR 1999; 48:4-8.
5. Cronquist A, Beach MJ, Johnston SP, da Silva A. Manufacturer's recall of rapid cartridge assay kits on the basis of false-positive Cryptosporidium antigen tests- Colorado, 2004. MMWR 2004; 53:198.
6. Xiao L, Alderisio K, Limor J, Royer M, Lal AA. Identification of species and sources of Cryptosporidium oocysts in storm waters with a smallsubunit rRNA-based diagnostic and genotyping tool. Appl Environ Microbiol 2000; 66(12):5492-5498.
7. Garcia LS. Diagnostic medical parasitology. 5th ed. Washington, DC: ASM Press, 2007.
8. Ortega YR, Cama VA. Foodborne transmission. In: Fayer R, Xiao L, eds. Cryptosporidium and cryptosporidiosis. 2nd ed. Boca Raton, FL: CRC Press, 2008: 289-304.
9. Johnston SP, Ballard MM, Beach MJ, Causer L, Wilkins PP. Evaluation of three commercial assays for detection of Giardia and Cryptosporidium organisms in fecal specimens. J Clin Microbiol 2003; 41 (2):623-626.
10. Garcia LS, Shimizu RY, Novak S, Carroll M, Chan F. Commercial assay for detection of Giardia lamblia and Cryptosporidium parvum antigens in human fecal specimens by rapid solid-phase qualitative immunochromatography. J Clin Microbiol 2003;41(1):209-212.